Levosulpiride 12.5mg/ml Injection in pharma franchise in Punjab

Levosulpiride 12.5mg/ml Injection in PCD pharma franchise in Nashik

Levosulpiride 12.5mg/ml Injection in top pharma company in Visakhapatnam

Levosulpiride 12.5mg/ml Injection in PCD pharma supplier in Jodhpur

Levosulpiride 12.5mg/ml Injection in pharma franchise company in India
Levosulpiride 12.5mg/ml Injection in pharma distributor in Faridabad

Home/Products /levosulpiride-12-point-5mg-ml-injection-lesutype-injection

About the Product

Description


Lesutype 25 Injection is a pharmaceutical formulation containing Levosulpiride, a potent medication known for its therapeutic effects in managing various gastrointestinal and psychological conditions. Levosulpiride is a substituted benzamide derivative that acts primarily as a dopamine D2 receptor antagonist. This injection is designed to provide rapid relief from symptoms associated with gastrointestinal disorders and certain psychiatric conditions, making it a versatile option in clinical practice.

Levosulpiride is particularly effective in treating functional gastrointestinal disorders, such as irritable bowel syndrome (IBS) and dyspepsia. It works by enhancing gastrointestinal motility and reducing symptoms like bloating, abdominal pain, and discomfort. Additionally, Levosulpiride has antidepressant properties, making it beneficial for patients experiencing anxiety and depressive disorders. By modulating neurotransmitter activity in the brain, it helps improve mood and alleviate symptoms of depression.

Lesutype Injection is administered under the supervision of a healthcare professional, ensuring that patients receive the appropriate dosage tailored to their specific needs. The injection form allows for quick absorption and onset of action, providing timely relief for patients who may be unable to take oral medications due to nausea or vomiting.

While Lesutype Injection is generally well-tolerated, some individuals may experience side effects. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. It is essential for patients to discuss any pre-existing conditions or medications with their healthcare provider to avoid potential interactions and ensure safe use.

Lesutype Injection is classified under General and OTC medicines, making it accessible for healthcare providers to prescribe in various clinical settings. Its dual action on both gastrointestinal and psychological symptoms makes it a valuable addition to treatment regimens for patients suffering from these conditions.

Generally well-tolerated; however, some individuals may experience drowsiness, dizziness, or gastrointestinal disturbances. Discontinue use if any adverse reactions occur.

Lesutype Injection is indicated for the treatment of functional gastrointestinal disorders and certain psychiatric conditions, including anxiety and depression.

Consult a healthcare professional before use, especially if pregnant, nursing, or on medication.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levosulpiride 12.5 mg/ml Injection in the PCD pharma franchise market?

Levosulpiride Injection is used for gastrointestinal motility disorders such as severe nausea, vomiting, functional dyspepsia, bloating, and postoperative gastric stasis. It is a strong gastroenterology injectable segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this injection in their product range?

Medical distributors and wholesalers can benefit from consistent demand in hospitals, emergency wards, and gastroenterology departments. It is widely used when rapid action is required or when oral administration is not possible, ensuring steady institutional sales and repeat hospital orders.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for injectable and gastro formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this injectable gastro product?

Wholesalers and medical agencies benefit from hospital procurement, inpatient care demand, emergency usage, and gastroenterology prescription flow when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this injectable formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.